NYSE - Delayed Quote USD
Charles River Laboratories International, Inc. (CRL)
At close: November 15 at 4:00 PM EST
After hours: November 15 at 6:00 PM EST
Research Analysis
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 15 | 12 | 17 | 18 |
| Avg. Estimate | 2.54 | 2.38 | 10.18 | 10.31 |
| Low Estimate | 2.45 | 2.19 | 10 | 9.18 |
| High Estimate | 2.65 | 2.68 | 10.31 | 10.8 |
| Year Ago EPS | 2.46 | 2.27 | 10.67 | 10.18 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 12 | 9 | 16 | 17 |
| Avg. Estimate | 985.03M | 990.98M | 4.03B | 4.1B |
| Low Estimate | 965.5M | 967.4M | 4.01B | 3.78B |
| High Estimate | 1B | 1.02B | 4.05B | 4.53B |
| Year Ago Sales | 1.01B | 1.01B | 4.13B | 4.03B |
| Sales Growth (year/est) | -2.81% | -2.03% | -2.40% | 1.85% |
Earnings History
| CURRENCY IN USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | 2.4 | 2.06 | 2.39 | 2.42 |
| EPS Actual | 2.46 | 2.27 | 2.8 | 2.59 |
| Difference | 0.06 | 0.21 | 0.41 | 0.17 |
| Surprise % | 2.40% | 9.98% | 16.97% | 6.88% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 2.54 | 2.38 | 10.18 | 10.31 |
| 7 Days Ago | 2.54 | 2.41 | 10.16 | 10.36 |
| 30 Days Ago | 2.51 | 2.48 | 10 | 10.52 |
| 60 Days Ago | 2.52 | 2.51 | 10.01 | 10.86 |
| 90 Days Ago | 2.52 | 2.51 | 10.01 | 10.94 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 10 | 5 | 11 | 6 |
| Up Last 30 Days | 9 | 4 | 11 | 5 |
| Down Last 7 Days | 2 | 2 | -- | 8 |
| Down Last 30 Days | 3 | 6 | -- | 11 |
Growth Estimates
| CURRENCY IN USD | CRL | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 3.45% | -- | -- | 5.00% |
| Next Qtr. | 4.74% | -- | -- | 12.00% |
| Current Year | -4.55% | -- | -- | 2.10% |
| Next Year | 1.26% | -- | -- | 12.20% |
Upgrades & Downgrades
| Maintains | TD Cowen: Hold to Hold | 11/11/2024 |
| Maintains | UBS: Buy to Buy | 11/7/2024 |
| Maintains | Evercore ISI Group: In-Line to In-Line | 11/7/2024 |
| Initiated | CLSA: Underperform | 10/23/2024 |
| Initiated | Redburn Atlantic: Sell | 10/14/2024 |
| Downgrade | Evercore ISI Group: Outperform to In-Line | 10/7/2024 |
Related Tickers
IQV IQVIA Holdings Inc.
192.68
-5.06%
ICLR ICON Public Limited Company
189.64
-5.19%
MEDP Medpace Holdings, Inc.
310.63
-7.23%
MTD Mettler-Toledo International Inc.
1,179.58
-4.70%
IDXX IDEXX Laboratories, Inc.
420.91
-0.65%
LH Labcorp Holdings Inc.
235.21
-1.25%
NOTV Inotiv, Inc.
2.6800
-1.83%
A Agilent Technologies, Inc.
127.07
-2.42%
DHR Danaher Corporation
230.50
-3.71%
WAT Waters Corporation
358.46
-4.85%